Charlotte's Web Holdings (CWBHF) Cost of Revenue (2021 - 2026)
Charlotte's Web Holdings (CWBHF) posted quarterly Cost of Revenue of $6.0 million for Q1 2026, down 1.28% year-over-year from $6.0 million in Q1 2025, and down 28.45% quarter-over-quarter from $8.3 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Cost of Revenue (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has reported Cost of Revenue for 6 consecutive years, with $6.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cost of Revenue fell 1.28% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $28.1 million (down 3.78% YoY), while the FY2025 annual figure was $28.2 million, down 0.74% from the prior year.
- Cost of Revenue retreated to $6.0 million in Q1 2026 per CWBHF's latest filing, from $8.3 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $29.4 million in Q4 2022 and bottomed at $5.2 million in Q1 2024.
- Historically, Cost of Revenue has averaged $8.5 million across 5 years, with a median of $7.1 million in 2023.
- Annual changes were most pronounced in 2022 — Cost of Revenue soared 42.74% — and 2023, when it sank 76.07%.
- Charlotte's Web Holdings' Cost of Revenue stood at $29.4 million in 2022, then tumbled by 76.07% to $7.0 million in 2023, then climbed by 7.53% to $7.6 million in 2024, then gained by 9.9% to $8.3 million in 2025, then slipped by 28.45% to $6.0 million in 2026.
- Business Quant data shows CWBHF's Cost of Revenue at $6.0 million in Q1 2026, $8.3 million in Q4 2025, and $7.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Charlotte's Web Holdings | 63.18 Mn | 49.19 Mn | 5.16 Mn | 5.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.70 Mn |
| Jun 30, 2026 | 5.70 Mn |
| Mar 31, 2026 | 5.96 Mn |
| Mar 31, 2026 | 5.96 Mn |
| Dec 31, 2025 | 8.32 Mn |
| Dec 31, 2025 | 8.32 Mn |
| Sep 30, 2025 | 7.03 Mn |
| Sep 30, 2025 | 7.03 Mn |
| Jun 30, 2025 | 6.82 Mn |
| Jun 30, 2025 | 6.82 Mn |
| Mar 31, 2025 | 6.03 Mn |
| Mar 31, 2025 | 6.03 Mn |
| Dec 31, 2024 | 7.57 Mn |
| Dec 31, 2024 | 7.57 Mn |
| Sep 30, 2024 | 5.91 Mn |
| Sep 30, 2024 | 5.91 Mn |
| Jun 30, 2024 | 9.71 Mn |
| Jun 30, 2024 | 9.71 Mn |
| Mar 31, 2024 | 5.21 Mn |
| Mar 31, 2024 | 5.21 Mn |